• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STRYKER NEUROVASCULAR CORK SURPASS EVOLVE 5.0MM X 40MM - PMAS; INTRACRANIAL ANEURYSM FLOW DIVERTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STRYKER NEUROVASCULAR CORK SURPASS EVOLVE 5.0MM X 40MM - PMAS; INTRACRANIAL ANEURYSM FLOW DIVERTER Back to Search Results
Model Number FDS50040
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hemorrhage/Bleeding (1888); Visual Impairment (2138); Thrombosis/Thrombus (4440)
Event Date 09/15/2020
Event Type  Injury  
Manufacturer Narrative
The subject device remained implanted.
 
Event Description
It was reported that the patient had experienced acute central retinal artery thrombosis approximately 32 hours post deployment of the subject flow diverter.The patient experienced acute loss of vision in ipsilateral eye of implantation.The subject flow diverter was implanted in the cavernous segment of the internal carotid artery (ica) and no difficulties were encountered during the procedure.Patient received 6mg of ia tpa in carotid and external artery as a medical intervention to treat the thrombosis and loss of vision.The vision improved after the patent received the medication.16 hours post tpa patient¿s scan showed many microhemorrhages and medical management was used to following indication of hemorrhages.No other information was provided.
 
Event Description
It was reported that the patient had experienced acute central retinal artery thrombosis approximately 32 hours post deployment of the subject flow diverter.The patient experienced acute loss of vision in ipsilateral eye of implantation.The subject flow diverter was implanted in the cavernous segment of the internal carotid artery (ica) and no difficulties were encountered during the procedure.Patient received 6mg of ia tpa in carotid and external artery as a medical intervention to treat the thrombosis and loss of vision.The vision improved after the patent received the medication.16 hours post tpa patient¿s scan showed many microhemorrhages and medical management was used to following indication of hemorrhages.No other information was provided.
 
Manufacturer Narrative
Due to the automated mes system there are controls in the manufacturing process to ensure the product met specifications upon release.Visual and functional testing could not be performed since the device was implanted in the patient.The reported event is covered in the device directions for use (dfu).As well, the risk of the reported event is documented in the risk documentation and there are current controls to mitigate the risk of the as reported event.Based upon medical review, the harm observed in the complaint is anticipated in nature as per the device risk assessment.As a product related root cause does not apply and the issue is due to a known physiological effect of the procedure and/or patient condition noted with the directions for use, product labeling and/or risk documentation files, an assignable cause of anticipated procedural complication will be assigned to this complaint.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SURPASS EVOLVE 5.0MM X 40MM - PMAS
Type of Device
INTRACRANIAL ANEURYSM FLOW DIVERTER
Manufacturer (Section D)
STRYKER NEUROVASCULAR CORK
ida industrial estate
model farm road
cork NA
EI  NA
MDR Report Key10659909
MDR Text Key211002858
Report Number3008881809-2020-00297
Device Sequence Number1
Product Code OUT
UDI-Device Identifier07613327375329
UDI-Public07613327375329
Combination Product (y/n)N
PMA/PMN Number
P170024
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup
Report Date 12/02/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/10/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date04/22/2023
Device Model NumberFDS50040
Device Catalogue NumberFDS50040
Device Lot Number22241704
Was Device Available for Evaluation? No
Date Manufacturer Received11/05/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age64 YR
-
-